GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynAct Pharma AB (OSTO:SYNACT) » Definitions » PB Ratio

SynAct Pharma AB (OSTO:SYNACT) PB Ratio : 1.45 (As of May. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is SynAct Pharma AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-22), SynAct Pharma AB's share price is kr7.195. SynAct Pharma AB's Book Value per Share for the quarter that ended in Dec. 2023 was kr4.95. Hence, SynAct Pharma AB's PB Ratio of today is 1.45.

The historical rank and industry rank for SynAct Pharma AB's PB Ratio or its related term are showing as below:

OSTO:SYNACT' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3779.32
Current: 1.45

During the past 8 years, SynAct Pharma AB's highest PB Ratio was 3779.32. The lowest was 0.00. And the median was 0.00.

OSTO:SYNACT's PB Ratio is ranked better than
71.45% of 1317 companies
in the Biotechnology industry
Industry Median: 2.56 vs OSTO:SYNACT: 1.45

During the past 12 months, SynAct Pharma AB's average Book Value Per Share Growth Rate was 16.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 97.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 54.90% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of SynAct Pharma AB was 97.10% per year. The lowest was -26.80% per year. And the median was 7.30% per year.

Back to Basics: PB Ratio


SynAct Pharma AB PB Ratio Historical Data

The historical data trend for SynAct Pharma AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynAct Pharma AB PB Ratio Chart

SynAct Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 9.75 68.15 177.40 19.10 1.78

SynAct Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.10 8.51 9.80 2.71 1.78

Competitive Comparison of SynAct Pharma AB's PB Ratio

For the Biotechnology subindustry, SynAct Pharma AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynAct Pharma AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynAct Pharma AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where SynAct Pharma AB's PB Ratio falls into.



SynAct Pharma AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

SynAct Pharma AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=7.195/4.953
=1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


SynAct Pharma AB  (OSTO:SYNACT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


SynAct Pharma AB PB Ratio Related Terms

Thank you for viewing the detailed overview of SynAct Pharma AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SynAct Pharma AB (OSTO:SYNACT) Business Description

Traded in Other Exchanges
Address
Sheelevagen 2, Lund, SWE, 223 81
SynAct Pharma AB is a clinical-stage biotech company focused on resolving inflammation through selective activation of the melanocortin system. The company has a platform technology based on a new class of drug candidates that target acute exacerbations in chronic inflammatory diseases with the primary aim of stimulating natural healing mechanisms. AP1189, the company's lead drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.

SynAct Pharma AB (OSTO:SYNACT) Headlines

No Headlines